Major depressive disorder is currently the fourth largest contributor to the worldwide burden of disease. Direct and indirect costs associated with depression place a significant burden on the health care system and society. Despite the development of new antidepressant medications, the management of patients with depression remains a therapeutic challenge. Obtaining a response in antidepressant therapy-commonly defined in clinical trials as an improvement of >erotonergic and noradrenergic neurotransmission, will increase the likelihood of remission.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
remission critical
4
critical outcome
4
outcome depression
4
depression treatment
4
treatment major
4
major depressive
4
depressive disorder
4
disorder currently
4
currently fourth
4
fourth largest
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!